ヘリオスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/03/31 | 1,166 | 1,172 | 1,136 | 1,163 | -14 | -1.2% | 168,000 |
| 2022/03/30 | 1,192 | 1,192 | 1,167 | 1,177 | +15 | +1.3% | 128,900 |
| 2022/03/29 | 1,133 | 1,166 | 1,130 | 1,162 | +20 | +1.8% | 147,800 |
| 2022/03/28 | 1,202 | 1,202 | 1,142 | 1,142 | -72 | -5.9% | 163,200 |
| 2022/03/25 | 1,224 | 1,228 | 1,174 | 1,214 | +10 | +0.8% | 203,400 |
| 2022/03/24 | 1,196 | 1,267 | 1,188 | 1,204 | -6 | -0.5% | 329,100 |
| 2022/03/23 | 1,200 | 1,227 | 1,187 | 1,210 | +28 | +2.4% | 222,100 |
| 2022/03/22 | 1,225 | 1,253 | 1,172 | 1,182 | -27 | -2.2% | 249,000 |
| 2022/03/18 | 1,140 | 1,221 | 1,128 | 1,209 | +92 | +8.2% | 339,000 |
| 2022/03/17 | 1,116 | 1,132 | 1,074 | 1,117 | +31 | +2.9% | 333,600 |
| 2022/03/16 | 1,080 | 1,109 | 1,076 | 1,086 | +19 | +1.8% | 429,400 |
| 2022/03/15 | 1,060 | 1,082 | 1,056 | 1,067 | -3 | -0.3% | 173,100 |
| 2022/03/14 | 1,116 | 1,116 | 1,054 | 1,070 | -50 | -4.5% | 299,100 |
| 2022/03/11 | 1,141 | 1,141 | 1,103 | 1,120 | -33 | -2.9% | 183,800 |
| 2022/03/10 | 1,131 | 1,157 | 1,096 | 1,153 | +73 | +6.8% | 336,200 |
| 2022/03/09 | 1,084 | 1,095 | 1,027 | 1,080 | -30 | -2.7% | 475,700 |
| 2022/03/08 | 1,096 | 1,138 | 1,095 | 1,110 | -6 | -0.5% | 394,800 |
| 2022/03/07 | 1,120 | 1,162 | 1,099 | 1,116 | -28 | -2.4% | 321,200 |
| 2022/03/04 | 1,197 | 1,263 | 1,134 | 1,144 | -56 | -4.7% | 830,600 |
| 2022/03/03 | 1,279 | 1,290 | 1,187 | 1,200 | -45 | -3.6% | 443,900 |
| 2022/03/02 | 1,239 | 1,295 | 1,223 | 1,245 | -22 | -1.7% | 487,800 |
| 2022/03/01 | 1,241 | 1,282 | 1,223 | 1,267 | +2 | +0.2% | 517,300 |
| 2022/02/28 | 1,170 | 1,276 | 1,163 | 1,265 | +72 | +6% | 623,300 |
| 2022/02/25 | 1,208 | 1,230 | 1,156 | 1,193 | +32 | +2.8% | 410,300 |
| 2022/02/24 | 1,135 | 1,211 | 1,133 | 1,161 | +38 | +3.4% | 568,600 |
| 2022/02/22 | 1,107 | 1,174 | 1,105 | 1,123 | -28 | -2.4% | 458,000 |
| 2022/02/21 | 1,133 | 1,182 | 1,108 | 1,151 | -29 | -2.5% | 342,100 |
| 2022/02/18 | 1,141 | 1,189 | 1,124 | 1,180 | -5 | -0.4% | 484,100 |
| 2022/02/17 | 1,200 | 1,223 | 1,158 | 1,185 | -13 | -1.1% | 615,700 |
| 2022/02/16 | 1,105 | 1,219 | 1,105 | 1,198 | +153 | +14.6% | 1,457,000 |
| 2022/02/15 | 1,010 | 1,086 | 996 | 1,045 | +42 | +4.2% | 307,600 |
| 2022/02/14 | 1,009 | 1,015 | 968 | 1,003 | -36 | -3.5% | 422,200 |
| 2022/02/10 | 1,047 | 1,061 | 1,036 | 1,039 | +4 | +0.4% | 155,900 |
| 2022/02/09 | 1,047 | 1,047 | 999 | 1,035 | -15 | -1.4% | 280,600 |
| 2022/02/08 | 1,034 | 1,065 | 1,027 | 1,050 | +1 | +0.1% | 128,800 |
| 2022/02/07 | 1,056 | 1,069 | 1,036 | 1,049 | -6 | -0.6% | 100,300 |
| 2022/02/04 | 1,050 | 1,059 | 1,022 | 1,055 | -11 | -1% | 154,500 |
| 2022/02/03 | 1,072 | 1,085 | 1,059 | 1,066 | -36 | -3.3% | 132,900 |
| 2022/02/02 | 1,060 | 1,105 | 1,060 | 1,102 | +55 | +5.3% | 88,800 |
| 2022/02/01 | 1,040 | 1,096 | 1,040 | 1,047 | +10 | +1% | 162,700 |
| 2022/01/31 | 1,037 | 1,050 | 1,018 | 1,037 | +4 | +0.4% | 131,000 |
| 2022/01/28 | 1,089 | 1,100 | 1,020 | 1,033 | -33 | -3.1% | 222,500 |
| 2022/01/27 | 1,086 | 1,095 | 1,060 | 1,066 | -4 | -0.4% | 258,600 |
| 2022/01/26 | 1,034 | 1,096 | 1,034 | 1,070 | +20 | +1.9% | 193,100 |
| 2022/01/25 | 1,142 | 1,158 | 1,029 | 1,050 | -18 | -1.7% | 407,000 |
| 2022/01/24 | 1,029 | 1,076 | 1,025 | 1,068 | +35 | +3.4% | 218,500 |
| 2022/01/21 | 1,059 | 1,068 | 1,023 | 1,033 | -50 | -4.6% | 254,600 |
| 2022/01/20 | 1,071 | 1,093 | 1,062 | 1,083 | +12 | +1.1% | 168,600 |
| 2022/01/19 | 1,110 | 1,114 | 1,065 | 1,071 | -72 | -6.3% | 296,500 |
| 2022/01/18 | 1,147 | 1,166 | 1,131 | 1,143 | -4 | -0.3% | 142,700 |
651～
700
件表示中 / 2309件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ヘリオス | 19,600円 | +395.9% | - | 0.00% | - | 5.45倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| ステムリム | 35,800円 | - | - | 0.00% | - | 2.91倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 大幸薬品 | 36,400円 | +11.1% | - | 0.00% | 33.21倍 | 2.26倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。不振の「クレベリン」など事業再構築中 |
| オンコリス | 70,300円 | +58.7% | - | 0.00% | - | 12.39倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
| Ｃｈｏｒｄｉａ | 24,900円 | - | - | 0.00% | - | 4.08倍 |
|
ＲＮＡ制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
市場注目の銘柄
チャート関連のコラム
